Hypothalamic involvement and biomarker candidacy in Alzheimer's disease in Down syndrome

This research explores the role of hypothalamic dysfunction as a potential mechanism and biomarker in Alzheimer's disease development among individuals with Down syndrome. The study contributes to understanding neuropathological pathways specific to this population, which shows elevated Alzheimer's risk due to trisomy 21.